Action SILCOPHL SILCO PHARMACEUTICALS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Silco Pharmaceuticals Limited

Actions

SILCOPHL

BD0495SILCO6

Cours en clôture Dhaka S.E.
Autres places de cotation
 00:00:00 15/05/2024 		Varia. 5j. Varia. 1 janv.
19,6 BDT -2,49% Graphique intraday de Silco Pharmaceuticals Limited +5,95% -16,24%
01/05 Silco Pharmaceuticals Limited annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 31 mars 2024 CI
07/02 Silco Pharmaceuticals Limited annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Silco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Silco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
Silco Pharmaceuticals Limited Recommends Cash Dividend for All Shareholders Excluding Directors for the Year Ended June 30, 2023
Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
Silco Pharmaceuticals Limited Approves Cash Dividend for the Year Ended June 30, 2022
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2022
37,316,700 Ordinary Shares of Silco Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2022.
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2020
Silco Pharmaceuticals Limited Reports Earnings Results for the Year Ended on June 30, 2020
Silco Pharmaceuticals Limited Signs First Export Agreement with Zaid Elyas Adil Ltd
27,053,300 Ordinary Shares of Silco Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2020.
Silco Pharmaceuticals Limited Recommends Dividend for the Year Ended June 30, 2019
Silco Pharmaceuticals Limited Announces Earnings Results for the Third Quarter and Nine Months Ended Period Ended on 31 March 2019
Silco Pharmaceuticals Limited has completed an IPO in the amount of BDT 300 million.
Silco Pharmaceuticals Limited has filed an IPO in the amount of BDT 300 million.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SILCOPHL
  4. Actualités Silco Pharmaceuticals Limited
  5. Autres langues